APHA
Back to Annual Meeting Page
 
American Public Health Association
133rd Annual Meeting & Exposition
December 10-14, 2005
Philadelphia, PA
APHA 2005
 
5008.0: Wednesday, December 14, 2005 - Board 1

Abstract #100492

Evaluation of the Wisconsin tuberculosis program's progress towards documentation of treatment improvement and completion of treatment in active cases of reported tuberculosis, Wisconsin 2000-2002

Monica L. Monteon, MS1, Christine M. Arcari, PhD, MPH2, Patrick Remington, MD, MPH3, Marty S. Kanarek, PhD3, and Tanya V. Oemig, RM (NRM)4. (1) Depatment of Population Health Sciences, University of Wisconsin, 610 N Walnut St, Madison, WI 53726, (2) Department of Population Health Sciences, University of Wisconsin-Madison Medical School, 605 WARF Building, Madison, WI 53726-2397, (608) 265-5491, carcari@wisc.edu, (3) Department of Population Health Sciences, University of Wisconsin-Madison, 760 WARF Building, 610 Walnut St., Madison, WI 53726, (4) Wisconsin Department of Health and Family Services, Wisconsin TB Program, 1 W Wilson, PO 2659, Madison, WI 53701

Objective: The Wisconsin Strategic Plan for the Elimination of Tuberculosis (TB) set goals of treatment completion at 90% and documentation of treatment improvement at 95% for all reported cases of TB. The objective of this study is to measure the success in achieving these goals. Methods: Data were abstracted from patient charts maintained by the Wisconsin TB Program. Treatment completion was considered for patients indicated for completion in <12 months. Documentation of treatment improvement included therapy adherence, culture conversion, and chest x-ray improvement for pulmonary cases and therapy adherence and clinical improvement for extrapulmonary cases. Results: A total of 249 TB cases were reported in Wisconsin between 2000 and 2002. Treatment completion was determined in 204 patients (148 pulmonary cases and 56 extrapulmonary cases) and 170 (87.1%) completed treatment in <12 months. There was a significant difference in treatment completion by site of disease, 89.9% for pulmonary cases and 66.1% for extrapulmonary cases (p<0.01). Documentation of treatment improvement was 61.2% among pulmonary cases and 83.6% among extrapulmonary cases (p<0.01). There was a significant decrease in the documentation rates for pulmonary patients during the study period (p<0.01). Conclusions: Barriers in Wisconsin need to be identified if we are to progress toward elimination of TB. While the goal of 90% treatment completion of all cases was nearly accomplished the goal of 95% documentation of treatment improvement was not achieved. This is important because case management of TB is necessary for control and prevention of TB in the United States.

Learning Objectives: The learning objectives are